FDA Approves Angiotech's Pulmonary Embolism Device
The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) sending the stock price soaring 65 cents to $2.35.
The FDA approved a pulmonary embolism device to be made by Angiotech Pharmaceuticals Inc. (Nasdaq: ANPI) sending the stock price soaring 65 cents to $2.35.
